IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $40,515 | +21.6% | 987,450 | +5.9% | 0.09% | +13.6% |
| Q1 2023 | $33,329 | -4.0% | 932,540 | +1.4% | 0.08% | -10.0% |
| Q4 2022 | $34,723 | -99.9% | 919,332 | +1.2% | 0.09% | -18.2% |
| Q3 2022 | $40,182,000 | -15.0% | 908,479 | -28.8% | 0.11% | -12.7% |
| Q2 2022 | $47,267,000 | -18.3% | 1,276,783 | -18.2% | 0.13% | +11.5% |
| Q1 2022 | $57,839,000 | +23.9% | 1,561,513 | +1.8% | 0.11% | +25.6% |
| Q4 2021 | $46,680,000 | +0.3% | 1,533,999 | +10.5% | 0.09% | -4.3% |
| Q3 2021 | $46,545,000 | +845.8% | 1,387,764 | +1024.9% | 0.09% | +840.0% |
| Q2 2021 | $4,921,000 | -9.8% | 123,367 | +1.7% | 0.01% | -16.7% |
| Q1 2021 | $5,454,000 | +21716.0% | 121,313 | +24162.6% | 0.01% | – |
| Q3 2017 | $25,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |